Shockwave Medical, Inc. - FORM 10-Q - EX-32.1 - EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SEC - May 10, 2021

Attached files

file filename
EX-32.2 - EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SEC - Shockwave Medical, Inc.swav-ex322_7.htm
EX-31.2 - EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13A-14( - Shockwave Medical, Inc.swav-ex312_9.htm
EX-31.1 - EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULES 13A-14( - Shockwave Medical, Inc.swav-ex311_6.htm
EX-10.1 - EX-10.1 - Shockwave Medical, Inc.swav-ex101_46.htm
10-Q - 10-Q - Shockwave Medical, Inc.swav-10q_20210331.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Shockwave Medical, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

Date: May 10, 2021

 

By:

 

/s/ Douglas Godshall

 

 

Douglas Godshall

 

 

President and Chief Executive Officer

 

Shockwave Medical, Inc. Reports